Your browser doesn't support javascript.
loading
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study.
Lhermitte, Ludovic; Barreau, Sylvain; Morf, Daniela; Fernandez, Paula; Grigore, Georgiana; Barrena, Susana; de Bie, Maaike; Flores-Montero, Juan; Brüggemann, Monika; Mejstrikova, Ester; Nierkens, Stefan; Burgos, Leire; Caetano, Joana; Gaipa, Giuseppe; Buracchi, Chiara; da Costa, Elaine Sobral; Sedek, Lukasz; Szczepanski, Tomasz; Aanei, Carmen-Mariana; van der Sluijs-Gelling, Alita; Delgado, Alejandro Hernández; Fluxa, Rafael; Lecrevisse, Quentin; Pedreira, Carlos E; van Dongen, Jacques J M; Orfao, Alberto; van der Velden, Vincent H J.
Afiliação
  • Lhermitte L; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France.
  • Barreau S; Institut Necker-Enfants Malades, Institut National de Recherche Médicale U1151, Laboratory of Onco-Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades, Université de Paris, Paris, France.
  • Morf D; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland.
  • Fernandez P; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland.
  • Grigore G; Cytognos SL, Salamanca, Spain.
  • Barrena S; Cytognos SL, Salamanca, Spain.
  • de Bie M; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.
  • Flores-Montero J; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.
  • Brüggemann M; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Mejstrikova E; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • Nierkens S; Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Burgos L; Translational and Clinical Research Program, Cancer Research Centre (IBMCC, CSIC-USAL), Cytometry Service, NUCLEUS, Salamanca, Spain.
  • Caetano J; Department of Medicine, University of Salamanca (USAL), Salamanca, Spain.
  • Gaipa G; Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Buracchi C; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.
  • da Costa ES; Department of Hematology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Sedek L; Department of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia.
  • Szczepanski T; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
  • Aanei CM; Applied Medical Research Center (CIMA), IDISNA, Clinica Universidad de Navarra (UNAV), Pamplona, Spain.
  • van der Sluijs-Gelling A; Hemato-Oncology Laboratory, Portuguese Institute of Oncology, Lisbon, Portugal.
  • Delgado AH; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy.
  • Fluxa R; Tettamanti Research Center, Pediatric Clinic University of Milano Bicocca, Monza, MB, Italy.
  • Lecrevisse Q; Pediatrics Institute IPPMG, Faculty of Medicine, Federal University of Rio de Janeiro, Av. Horacio Macedo, Predio do CT, CEP, Rio de Janeiro, 21941-914, Brazil.
  • Pedreira CE; Department of Microbiology and Immunology, Medical University of Silesia in Katowice, Zabrze, Poland.
  • van Dongen JJM; Department of Pediatric Hematology and Oncology, Medical University of Silesia in Katowice, Zabrze, Poland.
  • Orfao A; Laboratory of Hematology, University Hospital of Saint-Etienne, Saint-Etienne, France.
  • van der Velden VHJ; Department of Immunohematology and Blood Transfusion (IHB), Leiden University Medical Center (LUMC), Leiden, The Netherlands.
Mod Pathol ; 34(1): 59-69, 2021 01.
Article em En | MEDLINE | ID: mdl-32999413
ABSTRACT
Precise classification of acute leukemia (AL) is crucial for adequate treatment. EuroFlow has previously designed an AL orientation tube (ALOT) to guide toward the relevant classification panel and final diagnosis. In this study, we designed and validated an algorithm for automated (database-supported) gating and identification (AGI tool) of cell subsets within samples stained with ALOT. A reference database of normal peripheral blood (PB, n = 41) and bone marrow (BM; n = 45) samples analyzed with the ALOT was constructed, and served as a reference for the AGI tool to automatically identify normal cells. Populations not unequivocally identified as normal cells were labeled as checks and were classified by an expert. Additional normal BM (n = 25) and PB (n = 43) and leukemic samples (n = 109), analyzed in parallel by experts and the AGI tool, were used to evaluate the AGI tool. Analysis of normal PB and BM samples showed low percentages of checks (<3% in PB, <10% in BM), with variations between different laboratories. Manual analysis and AGI analysis of normal and leukemic samples showed high levels of correlation between cell numbers (r2 > 0.95 for all cell types in PB and r2 > 0.75 in BM) and resulted in highly concordant classification of leukemic cells by our previously published automated database-guided expert-supervised orientation tool for immunophenotypic diagnosis and classification of acute leukemia (Compass tool). Similar data were obtained using alternative, commercially available tubes, confirming the robustness of the developed tools. The AGI tool represents an innovative step in minimizing human intervention and requirements in expertise, toward a "sample-in and result-out" approach which may result in more objective and reproducible data analysis and diagnostics. The AGI tool may improve quality of immunophenotyping in individual laboratories, since high percentages of checks in normal samples are an alert on the quality of the internal procedures.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Algoritmos / Leucemia Mieloide Aguda / Imunofenotipagem / Leucócitos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Algoritmos / Leucemia Mieloide Aguda / Imunofenotipagem / Leucócitos Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article